The Quiet Rewrite of How NIH Scores Your R01: Three Factors, One That Matters Most, and SimplerNOFO

NIH did not send out a press release the day it changed the odds on your R01. It changed the scoring architecture instead. For applications with due dates in 2025 and after, NIH's Simplified Review Framework collapsed the five long-standing review criteria into three factors — and, critically, only two of them carry a numerical score. By mid-2026, study sections have run several full cycles under the new rules, which means the framework is no longer an announcement to plan around. It is the settled reality every reviewer now reads your application through, and a proposal written to the old five-criteria muscle memory is quietly leaving points on the table.

Paired with the parallel rollout of SimplerNOFO — HHS's effort to make the funding notices themselves shorter and more navigable — 2026 is the year the mechanics of NIH review and application look meaningfully different from what a mid-career investigator internalized a decade ago. Here is what actually changed, and how to write to it.

The three factors

The old system asked reviewers to score five separate criteria: Significance, Innovation, Approach, Investigator, and Environment. Each got its own attention, and a strong showing on one could visibly offset weakness on another. The Simplified Review Framework reorganizes those five into three factors:

Factor 1 — Importance of the Research (scored 1–9). This fuses the former Significance and Innovation criteria into one judgment. Reviewers make a single call on how important and how novel the work is, together, rather than arguing them separately.

Factor 2 — Rigor and Feasibility (scored 1–9). This maps almost entirely onto the Research Strategy's Approach section: experimental design, handling of pitfalls and alternatives, rigor, preliminary data, and whether the timeline is realistic.

Factor 3 — Expertise and Resources (sufficiency only — no score). This combines the former Investigator and Environment criteria into a binary determination: does the team and its institutional setting meet the bar to execute the work, yes or no? There is no numerical grade attached.

That last change is the one that reshapes strategy, and most applicants haven't fully absorbed it.

Why "sufficiency only" changes everything

Under the old framework, a celebrated investigator at a top-tier institution carried a scoring advantage into every review. Strong Investigator and Environment scores were real numbers that lifted the overall impact score and could partially compensate for a merely adequate approach. That compensation is gone.

Factor 3 is now pass/fail. A strong team and a world-class environment earn you a "meets" — and nothing more. They no longer add points; they simply clear a gate. The corollary is sharper than it first sounds: because the only two scored factors are Importance and Rigor/Feasibility, and Importance fuses significance with innovation, the Approach section is now the single largest driver of a scoreable, differentiating judgment on your application. A weak approach can no longer be rescued by an impressive biosketch.

This cuts two ways, and both are worth naming plainly. For early-stage investigators and teams at less prominent institutions, it is genuinely leveling — the reputational thumb on the scale is lighter, and a rigorous, well-designed approach competes on its merits. For established investigators who have leaned on reputation, it is a warning: the halo no longer scores. Either way, the writing implication is identical.

How to write to the new framework

Invest disproportionately in the Approach. Factor 2 is the only fully scored factor that maps directly to a section you control line by line. Experimental design, explicit handling of alternative outcomes and pitfalls, rigor and reproducibility, preliminary data, and a defensible timeline are no longer just good practice — they are where the differentiating score is made. If you triage your revision time, the Approach gets the most of it.

Fuse significance and innovation into one through-line. Because Factor 1 judges importance and novelty together, the worst thing you can do is present them as two disconnected arguments. The strongest applications draw a clean line: here is the gap that matters, and here is why our novel approach is the thing that closes it. Innovation untethered from significance reads as novelty for its own sake; significance without innovation reads as incremental. The framework rewards the connection.

Do not neglect Factor 3 just because it isn't scored. A "does not meet" on Expertise and Resources is not a lost point — it is a signal to the panel that the team can't execute, and it can sink an otherwise strong application. Every required expertise in the plan needs a visible owner on the team, and any specialized resource the approach depends on needs to be demonstrably available. The bar is binary, but falling below it is fatal.

Get the forms right. Affected activity codes must use the current form version (FORMS-I for the relevant cycles); the wrong version is grounds for withdrawal before a reviewer ever sees the science. This is an unforced-error category — check it twice.

What the framework does not cover

A crucial scoping point that trips up applicants: the Simplified Review Framework applies to most research project grants — the R01, R21, and their kin — but not to career development (K) awards, training and fellowship mechanisms (T and F), or several cooperative agreement mechanisms. If you are writing a K or an F, the older criteria and their distinct review structure still govern. Know which set of rules your mechanism lives under before you start writing, because the strategic advice diverges sharply between them.

SimplerNOFO: the other half of the change

While review was being restructured, the funding notices themselves were being rewritten. Under the HHS SimplerNOFO initiative, NIH is reformatting its Notices of Funding Opportunity to be more accessible, understandable, and actionable — cutting length, standardizing structure, and putting the information applicants actually need where they can find it. NIH's MIRA for Early Stage Investigators NOFO was the first to use the new format, with a broader rollout following.

For applicants, SimplerNOFO is mostly a quality-of-life improvement, but it carries a real behavioral warning: the notices look different now. Investigators who navigate NOFOs from memory — scrolling to the section they always scroll to — will find the furniture rearranged. Read the whole notice as if it's new, because for practical purposes it is, and the eligibility, budget, and review details you assume you know may sit somewhere else or read differently than the version you last applied under.

The takeaway

NIH restructured the scoring of your R01 without much fanfare, and by the middle of 2026 it is simply how review works. Five criteria became three factors; only two are scored; and the Approach section now carries more of the differentiating weight than any other part of your application, because the investigator-and-environment advantage that used to add points has been reduced to a pass/fail gate. Write to that reality — pour effort into rigor and feasibility, fuse significance with innovation into a single argument, clear the expertise gate cleanly, and read the newly reformatted SimplerNOFO notices from scratch. The rules changed quietly. Scoring well under them is a choice you make at the keyboard.